Upgrade to SI Premium - Free Trial

After-Hours Stock Movers 01/20: (ECYT) (XLNX) (FEYE) Higher; (OGXI) (SLM) (SRPT) Lower (more...)

January 20, 2016 5:51 PM
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) 41.8% LOWER; announced that data from the Phase 2 Spruce trial evaluating the combination of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles